One of the fascinating things about human life is that it can take on hugely different looks over time. This allows it to explore areas, which one would normally put well outside of its reach. Now, when you have such a dynamic in place, you can always expect some really interesting by-products, and yet none really turned out to be as interesting as technology. While technology’s case in the said context is constructed a whole lot from all what it has achieved so far, it is also inspired largely by how the creation secured those achievements. You see, the inventiveness of technology consistently made sure that our processes had a bigger aim than just plain efficiency. For instance, the creation would introduce a reality where literally even the most complicated structures will have a convenient vibe to them. The benefits of doing so will land throughout the spectrum in one way or the other, but their most meaningful foray only came once they entered our medical sector. Partnering outright ease with extensive medical procedures quickly transformed healthcare’s core meaning for us, but a recent partnership between MedArrive and Spect strongly conveys that is still plenty left in store.
MedArrive and Spect have officially announced the details about their collaboration, which is centered on providing home retinal screening to patients who are at high-risk of blindness. According to certain reports, the partnership will work by MedArrive providers using Spect’s telemedicine-powered platform to screen patients suffering from diseases like diabetic retinopathy, glaucoma, and age-related muscular degeneration. If we talk regarding the current situation, nearly one-third of the US population is dealing with diabetes, and many in this group also end up experiencing diabetic retinopathy. Even though the disease is fairly preventable, a lack of equipment portability and general inconvenience keeps the patients from getting the necessary care. Spect’s platform solves the issue by offering unprecedented logistics’ feasibility. Furthermore, the platform’s 95% accuracy rate does the rest in wrapping up a sensational selling pitch.
“In the near future, the AI will make this easier for the user by guiding them to the area, and the AI will decide when to capture the image, and ensure that the image is in focus and of the desired areas,” said Michael Leung, co-founder of Spect, when asked about the company’s technology.
MedArrive on the other hand will contribute to the partnership through its expansive network of EMS and care providers. Apart from tech setup, the limited reach of such services has been a major sticking point, but MedArrive can put an end to it by seamlessly delivering the facilities to underserved population groups.
